↓ Skip to main content

Cognitive Enhancement

Overview of attention for book
Attention for Chapter 11: Neural Targets in the Study and Treatment of Social Cognition in Autism Spectrum Disorder
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Neural Targets in the Study and Treatment of Social Cognition in Autism Spectrum Disorder
Chapter number 11
Book title
Cognitive Enhancement
Published in
Handbook of experimental pharmacology, November 2015
DOI 10.1007/978-3-319-16522-6_11
Pubmed ID
Book ISBNs
978-3-31-916521-9, 978-3-31-916522-6
Authors

Arshya Vahabzadeh, Samantha M. Landino, Beate C. Finger, William A. Carlezon Jr., Christopher J. McDougle, William A. Carlezon

Abstract

The purpose of this chapter is to present results from recent research on social cognition in autism spectrum disorder (ASD). The clinical phenomenology and neuroanatomical circuitry of ASD are first briefly described. The neuropharmacology of social cognition in animal models of ASD and humans is then addressed. Next, preclinical and clinical research on the neurohormone oxytocin is reviewed. This is followed by a presentation of results from preclinical and clinical studies on the excitatory amino acid glutamate. Finally, the role of neuroinflammation in ASD is addressed from the perspectives of preclinical neuroscience and research involving humans with ASD.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 83 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 18%
Student > Doctoral Student 9 11%
Researcher 9 11%
Student > Master 9 11%
Student > Ph. D. Student 6 7%
Other 12 14%
Unknown 23 28%
Readers by discipline Count As %
Medicine and Dentistry 18 22%
Psychology 16 19%
Neuroscience 8 10%
Agricultural and Biological Sciences 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 5 6%
Unknown 28 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2015.
All research outputs
#5,749,451
of 22,833,393 outputs
Outputs from Handbook of experimental pharmacology
#162
of 650 outputs
Outputs of similar age
#88,396
of 386,426 outputs
Outputs of similar age from Handbook of experimental pharmacology
#12
of 41 outputs
Altmetric has tracked 22,833,393 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 650 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 386,426 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.